| Valerie G Champagne, PHARMD | |
|
3009 Broussard St, Abbeville, LA 70510-4140 | |
| (337) 258-5716 | |
| Not Available |
| Full Name | Valerie G Champagne |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3009 Broussard St, Abbeville, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154032126 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 17219 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Valerie G Champagne, PHARMD 3009 Bares Rd, Abbeville, LA 70510-2690 Ph: (337) 258-5716 | Valerie G Champagne, PHARMD 3009 Broussard St, Abbeville, LA 70510-4140 Ph: (337) 258-5716 |
News Archive
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that it has initiated activities intended to complete the clinical development of the growth hormone secretagogue (GHS) / ghrelin agonist compound macimorelin (AEZS-130) which could be the first oral diagnostic test approved for growth hormone deficiency (GHD). Macimorelin is the International Non-proprietary Name (INN) designated for the compound by the World Health Organization (WHO).
Novartis Pharmaceuticals Canada Inc. (Novartis) announced today that Afinitor(R) (everolimus), a once-daily oral cancer treatment, has been approved by Health Canada for patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer, after failure of initial treatment with VEGF-receptor targeted therapies Sutent(R) (sunitinib) or Nexavar(R) (sorafenib).
The utilization rates of noninvasive diagnostic imaging procedures such as computed tomography scans, magnetic resonance imaging, and positron emission tomography for the Medicare population vary substantially from region to region, with Atlanta, GA, having the highest utilization rate and Seattle, WA, having the lowest, according to a study in the April issue of the American Journal of Roentgenology.
Study findings indicate that simulator training for otorhinolaryngology residents results in equal, if not superior, performance compared with traditional training that involves finite repetition of live procedures.
Millions of people with "wet" macular degeneration are prescribed a class of medication known as anti-VEGF drugs. But now scientists at The Scripps Research Institute (TSRI) have found that a drastic reduction of VEGF activity may do more harm than good.
› Verified 4 days ago
Marisa Rogers, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2509 Charity St, Abbeville, LA 70510 Phone: 337-893-2131 | |
Mr. Kyle Romero, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Veterans Memorial Dr, Abbeville, LA 70510 Phone: 337-893-9686 | |
Dr. Ryan Lassabe, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Veterans Memorial Dr, Abbeville, LA 70510 Phone: 337-893-9686 Fax: 337-898-9328 | |
Mark Mouton, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3005 Charity St, Abbeville, LA 70510 Phone: 337-893-4077 Fax: 337-893-4079 | |
Dr. Aaron Alexander Head, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3005 Veterans Memorial Dr, Abbeville, LA 70510 Phone: 337-893-4077 Fax: 337-893-4079 | |
Dr. Sarah Le, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2201 Veterans Memorial Dr, Abbeville, LA 70510 Phone: 337-898-1350 |